Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.


Journal

Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137

Informations de publication

Date de publication:
04 2021
Historique:
received: 19 10 2020
accepted: 16 12 2020
pubmed: 9 1 2021
medline: 27 1 2022
entrez: 8 1 2021
Statut: ppublish

Résumé

Many biomarkers have been proposed for the diagnosis of secondary hemophagocytic lymphohistiocytosis (HLH) in adults, but comparative studies are lacking. We analyzed ferritin, glycosylated ferritin, soluble CD25, CD163 and CD14, IL-6, IFN-γ, IL-18, IL-10, IL-1ß, IL-12p70, IL-17α, IP-10, and CXCL9 levels to differentiate HLH from sepsis in critically ill patients. Of 120 patients, HLH was confirmed for 14 patients. Among the biomarkers tested, ferritin, IL-18, and glycosylated ferritin were the most efficient parameters for early diagnosis of HLH. With a sensitivity set at 85%, ferritin, IL-18, and glycosylated ferritin were the biomarkers with the highest specificity: 84, 79, and 71% respectively. Combining IL-18 with the HScore provided a new score with an increased specificity compared to the HScore alone, 86% compared to 70% with a sensitivity set at 100%. A distinct cytokine pattern was highlighted in patients with malignancy-triggered HLH, with highly increased levels of INF-ɣ and CXCL9, compared to HLH secondary to infection. This is the largest study available to date, comparing diagnostic biomarkers for HLH on a cohort of critically ill adult patients. Serum ferritin was the most discriminating parameter for early diagnosis of secondary HLH. IL18

Identifiants

pubmed: 33417087
doi: 10.1007/s10875-020-00950-z
pii: 10.1007/s10875-020-00950-z
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Inflammation Mediators 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

658-665

Références

Cron RQ, Behrens EM. Cytokine storm syndrome. 1st ed. Springer International Publishing; 2019.
Janka GE, Lehmberg K. Hemophagocytic syndromes-an update. Blood Rev. 2014;28:135–42.
doi: 10.1016/j.blre.2014.03.002
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503–16.
doi: 10.1016/S0140-6736(13)61048-X
La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133:2465–77.
doi: 10.1182/blood.2018894618
Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.
doi: 10.1002/pbc.21039
Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheum. 2014;66:2613–20.
doi: 10.1002/art.38690
Cullis JO, Fitzsimons EJ, Griffiths WJ, et al. Investigation and management of a raised serum ferritin. Br J Haematol. 2018;181:331–40.
doi: 10.1111/bjh.15166
Naymagon L, Tremblay D, Mascarenhas J. Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis. Eur J Haematol. 2020;104:344–51.
doi: 10.1111/ejh.13391
Fardet L, Coppo P, Kettaneh A, Dehoux M, Cabane J, Lambotte O. Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis Rheum. 2008;58:1521–7.
doi: 10.1002/art.23415
Nabergoj M, Marinova M, Binotto G, Brugnaro L, Zaninotto M, Plebani M, et al. Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: a single- center study. Int J Lab Hematol. 2017;39:620–4.
doi: 10.1111/ijlh.12713
Hayden A, Lin M, Park S, Pudek M, Schneider M, Jordan MB, et al. Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH. Blood Adv. 2017;1:2529–34.
doi: 10.1182/bloodadvances.2017012310
Weiss ES, Girard-Guyonvarc'h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131:1442–55.
doi: 10.1182/blood-2017-12-820852
Cui Y, Xiong X, Ren Y, Wang F, Wang C, Zhang Y. CD163 as a valuable diagnostic and prognostic biomarker of sepsis-associated hemophagocytic lymphohistiocytosis in critically ill children. Pediatr Blood Cancer. 2019;66:e27909.
doi: 10.1002/pbc.27909
Maruoka H, Inoue D, Takiuchi Y, Nagano S, Arima H, Tabata S, et al. IP-10/ CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol. 2014;93:393–401.
doi: 10.1007/s00277-013-1878-y
Koh H, Nanno S, Katayama T, Hirose A, Nakamae M, Hino M, et al. Diagnostic usefulness of plasma presepsin (soluble CD14-subtype) for diagnosing hemophagocytic syndrome in hematological malignancies. Leuk Lymphoma. 2017;58:2489–92.
doi: 10.1080/10428194.2017.1292356
Xu XJ, Tang YM, Song H, Yang SL, Xu WQ, Zhao N, et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr. 2012;160:984–90.
doi: 10.1016/j.jpeds.2011.11.046
Tabata C, Tabata R. Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome. Ann Hematol. 2012;91:63–71.
doi: 10.1007/s00277-011-1239-7
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.
doi: 10.1378/chest.101.6.1644
Worwood M, Cragg SJ, Wagstaff M, Jacobs A. Binding of human serum ferritin to concanavalin A. Clin Sci. 1979;56:83–7.
doi: 10.1042/cs0560083
R Core Team, R Foundation for Statistical Computing, Vienna, Austria. R: a language and environment for statistical computing. Available at: https://www.R-project.org/ . Accessed 1 Apr 2020.
Le S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1–18.
doi: 10.18637/jss.v025.i01
Lachmann G, Knaak C, Vorderwülbecke G, la Rosée P, Balzer F, Schenk T, et al. Hyperferritinemia in critically ill patients. Crit Care Med. 2020;48:459–65.
doi: 10.1097/CCM.0000000000004131
Knaak C, Nyvlt P, Schuster FS, Spies C, Heeren P, Schenk T, et al. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore. Crit Care. 2020;24:244.
doi: 10.1186/s13054-020-02941-3
Carcillo JA, Shakoory B. Cytokine storm and sepsis-induced multiple organ dysfunction syndrome. In: Cron RQ, Behrens EM, editors. Cytokine storm syndrome. Springer International Publishing; 2019. pp. 451–464.
Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29:401–9.
doi: 10.1093/intimm/dxx031

Auteurs

France Debaugnies (F)

Laboratory of Translational Research, Centre Hospitalier Universitaire Brugmann, Université libre de Bruxelles, Brussels, Belgium. france.debaugnies@lns.etat.lu.
Medical Biology Department, Laboratoire National de Santé, Dudelange, Luxembourg. france.debaugnies@lns.etat.lu.

Bhavna Mahadeb (B)

Microbiology Department, LHUB-ULB, Université libre de Bruxelles, Brussels, Belgium.

Carole Nagant (C)

Immunology Department, LHUB-ULB, Université libre de Bruxelles, Brussels, Belgium.

Nathalie Meuleman (N)

Hematology Department, Jules Bordet Institute, Brussels, Belgium.

David De Bels (D)

Department of Intensive Care, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

Fleur Wolff (F)

Clinical Chemistry Department, LHUB-ULB, Université libre de Bruxelles, Brussels, Belgium.

Philippe Gottignies (P)

Department of Intensive Care, Hôpitaux IRIS-Sud, Brussels, Belgium.

Adriano Salaroli (A)

Hematology Department, Jules Bordet Institute, Brussels, Belgium.

Patricia Borde (P)

Medical Biology Department, Laboratoire National de Santé, Dudelange, Luxembourg.

Michel Voué (M)

Physics of Materials and Optics Unit, University of Mons, Mons, Belgium.

Francis Corazza (F)

Laboratory of Translational Research, Centre Hospitalier Universitaire Brugmann, Université libre de Bruxelles, Brussels, Belgium.
Immunology Department, LHUB-ULB, Université libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH